Daniel Soland to permanently join Idera Pharmaceuticals, Inc. (IDRA) as Chief Operating Officer
Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) has confirmed that that Daniel Soland, who has has been involved with Idera as a consultant is set to join
Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) has confirmed that that Daniel Soland, who has has been involved with Idera as a consultant is set to join
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.